Pacira BioSciences, Inc. (PCRX)
Fixed asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 700,966 | 694,957 | 690,310 | 681,754 | 674,978 | 665,689 | 669,229 | 669,173 | 666,823 | 654,062 | 614,318 | 580,497 | 541,533 | 510,887 | 500,649 | 440,564 | 427,221 | 421,097 | 408,298 | 435,397 |
| Property, plant and equipment | US$ in thousands | — | — | — | — | — | — | 180,310 | 181,617 | 254,389 | 193,646 | 191,279 | 189,767 | 264,811 | 159,235 | 224,554 | 144,822 | 136,688 | 125,527 | 113,297 | 108,105 |
| Fixed asset turnover | — | — | — | — | — | — | 3.71 | 3.68 | 2.62 | 3.38 | 3.21 | 3.06 | 2.04 | 3.21 | 2.23 | 3.04 | 3.13 | 3.35 | 3.60 | 4.03 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $700,966K ÷ $—K
= —
The fixed asset turnover ratio measures the efficiency with which a company generates sales revenue from its investment in fixed assets. A higher fixed asset turnover ratio indicates that the company is better utilizing its fixed assets to generate sales.
Based on the data provided for Pacira BioSciences, Inc., the trend of the fixed asset turnover ratio shows fluctuations over the quarters from March 2020 to June 2022. The ratio peaked at 4.03 in March 2020, indicating that the company generated $4.03 in sales for every dollar invested in fixed assets. However, the ratio gradually decreased to 2.23 in June 2021 before starting to recover.
From September 2021 to March 2023, the fixed asset turnover ratio generally improved, reaching a high of 3.71 in June 2023. This suggests that Pacira BioSciences enhanced its efficiency in utilizing fixed assets to generate sales during this period.
It is important to note that the fixed asset turnover ratios for the quarters ending September 2023 and beyond are not available (indicated as "—" in the data). This missing data limits the ability to provide a complete analysis of the company's fixed asset turnover trend beyond June 2023.
In summary, Pacira BioSciences' fixed asset turnover ratio has demonstrated fluctuations over the analyzed period, showing both improvements and declines in the efficiency of utilizing fixed assets to generate revenue. Further data beyond June 2023 would be needed to assess the company's recent performance in this aspect.
Peer comparison
Dec 31, 2024